The dalbaheptide antibiotic INA 9301 was isolated from a culture of Amycolatopsis orientalis. By using a combination of mass spectrometry and NMR spectroscopy, INA 9301 was assessed as N,N-dimethylvancomycin. Detailed 13 C NMR characteristics of INA9301 in D 2 O and DMSO-d 6 are presented, together with 2D 1 H-1 H ROESY and 1 H-13 C gHMBC data, which confirmed the configurations of the asymmetric centers and spatial conformational shape of the molecule in aqueous solution.
Dalbaheptides form a group of polycyclic glycopeptide antibiotics that are effective against many Gram-positive pathogenic bacteria due to their unique ability to suppress the biosynthesis of peptidoglycan of bacterial cell walls. During the screening of new natural glycopeptide antibiotics in the culture of Amycolatopsis orientalis, we isolated, by chromatography (see Experimental), a biologically active compound registered as INA 9301, along with other products of Actinomyces metabolism in a mutagenized microbial population. This compound had a pronounced absorption at 280 nm in its UV spectrum, characteristic of dalbaheptide antibiotics [1] [2] [3] . The chromatographic properties of this compound (both on direct silica gel and reversed C-18 phases) differ from those of the most important dalbahepide antibiotics vancomycin (Figure 1 , R=H) and teucoplanin. In this paper, we describe the structural analysis of INA9301, with emphasis on NMR spectroscopic features.
Structural analysis of INA 9301 was started from MALDI TOF mass spectrometry and 1 clearly revealed the presence in this compound of an α-(1→2)-linked vancosaminyl-β-glucoside disaccharide fragment, similar to that presented in vancomycin ( Figure 1 ). The most intensive peaks in the MALDI TOF spectrum ( Figure 2 ) correspond to ions with m/z 1477-1482. These peaks can be explained by a superposition of M + and (M+H) + and corresponding isotope peaks, which complicated the attribution of the signals. To assess the correct molecular mass value of INA 9301, Ion Cyclotron Resonance (ICR) spectrometry was applied to show only one intense peak at m/z 738.73 in the spectrum. This peak referred to a double charged particle corresponding to a mass of 1477.46. This value is higher than that of vancomycin (1447.43) by 30 Da, and this difference allowed one to suggest that the structure of the antibiotic INA 9301 differs from that of vancomycin by the presence of two extra methyl groups.
To assess the location of the methyl groups mentioned above, the structure of INA 9301 was studied also by Collision Induced Decomposition (CID) mass spectrometry. Thus, the fragmentation of the ion at m/z 738.73 [M 2+ ], which was detected in the ICR spectrum under CID, resulted in the formation of the dominant ion at m/z=1333.36. This ion could be generated by the elimination of the vancosamine residue from the [M + ] ion. In addition, a minor peak at m/z 1171.27 was detected, which could be generated by elimination of both vancosamine and glucose residues. These facts evidenced that the structural elements, which differentiate vancomycin and INA 9301, are located in the aglycon moiety of INA 9301.
Further investigation of INA 9301was then continued using NMR spectroscopic methods. The 1 H NMR spectrum in D 2 O ( Figure 3 ) contained both wellresolved groups and very broadened signals; this is common in the spectra of vancomycin, eremomycin and their derivatives [4] [5] [6] . It was noticeable that the 1 H NMR spectrum of INA 9301 contained an intensive nine-proton singlet at δ 3.35 ppm, which could be attributed to three equivalent CH 3 groups.
The 13 C NMR spectrum of INA 9301 ( Figure 4 ) contained sixty-six signals of different intensity and width. Five of them belong to CH 3 groups, four to -CH 2 -groups, thirty-two -to CH groups, and twentyfive to quaternary carbon atoms; all these were attributed by attached proton test ("APT") experiments.
The 1 H and 13 C NMR spectra in D 2 O ( (Table 1) , and only the signals of the spin system of the fragment bearing the elements P1-P5 differed from the spectral data of vancomycin (Table 1) . Particularly, the chemical shift of the α1 carbon in the 13 C NMR spectrum of INA 9301 was much more downfield (+13.3 ppm) in comparison with that in the spectrum of vancomycin. On the contrary, the signal for the P-4 CH 2 -group was shifted upfield in the spectrum of INA 9301 (-3.4 ppm).
The characteristic signal of the CH 3 -N (P5) group at δ 32.9 ppm in the 13 C NMR spectrum of vancomycin was absent in that of INA 9301. Instead of this, an intense peak at δ 53.8 ppm was observed in the 13 C NMR spectrum of INA 9301. The HSQC spectrum showed a correlation between this peak and the nineproton singlet at δ 3.35 ppm in the 1 H NMR spectrum. These observations allowed us to assume that P5 is represented by three N-connected methyl groups. The analysis of the HMBC spectrum confirmed that the nine-proton singlet belongs to three equivalent CH 3 groups (within P1-P5 spinsystem) connected to the same N-atom. Indeed, the presence of the cross-peak of P5 protons and α1 carbon (δ H /δ C 3.35/75.0, Figure 5 and Table 1 ), as well as the long-range correlation peak between the protons and carbons of the P5 methyl groups (δ H /δ C 3.35/53.8) evidenced once again that all three P5 methyls are linked to the same nitrogen atom.
The downfield shifts of P5 itself (CH 3 N) and α1 (CHN) groups in the 13 C NMR spectrum of INA 9301 in comparison with the corresponding signals in Complete assignment of the signals in the 1 H and 13 C NMR spectra of INA 9301 and comparison of these with those in the spectrum of vancomycin allowed us to conclude that the presence of two extra methyl groups is the only structural difference between these compounds.
Additionally, the ROESY spectrum of INA 9301 showed non-trivial correlation peaks ( Figure 6 , Thus, the above experimental data led to the conclusion that the INA 9301 antibiotic is N,N-dimethyl-vancomycin (Figure 1 , R = CH 3 ). Its structure is identical to that of the antibiotic M43A, which was previously elucidated by X-ray [5] and G2/G3 G4/G3 P5/α1 [4, 5] , but not with the use of MALDI TOF, ICR, and CID spectrometry in combination with 13 C NMR spectroscopy, and more advanced 2D HMBC and ROESY NMR methods, as in the present study, which, similar to X-ray analysis, permitted the determination of the stereo configurations of the asymmetric centers.
The similar analysis of the NMR spectra of the antibiotic INA 9301 in DMSO-d 6 solution ( Table 2) confirmed again the structure of N,N-dimethylvancomycin as determined by the NMR experiments in D 2 O solution.
Experimental
Analytical HPLC was performed on an Alltima column, 4 x 250 mm, with ODS silica gel (5μm; Altech, USA) by elution in the gradient of organic modifier [9] . The eluate was monitored by combination of a UV double wave detector (225 nm and 280 nm; spectrophotometer 155, Gilson, France) and an ELSD 2000 detector (Altech, USA).
Crude INA 9301 was isolated from the culture supernatant by ion-exchange chromatography [8] .
The crude material was analyzed and purified by HPLC on a column conditioned by an aqueous solution of CF 3 COOH (1mL/L) in a gradient mixture of 45% CH 3 CN, 45% THF, and 10% H 2 O with the addition of CF 3 COOH (1mL/L). The product obtained (26.6 mg) was dissolved in 4 mL of starting buffer [9] , applied to an Alltima column (10 x 250 mm), and then eluted with a gradient composition of liquid phase at 4 mL/min. Fractions of 4 mL were collected and then analyzed by HPLC on a column conditioned with an aqueous solution of 0.05M KH 2 PO 4 (pH=3) in the gradient CH 3 CN. Fractions of 19.0-23.0 min, which were characterized by higher UV absorption and exhibited antimicrobial activity, were combined and freeze-dried to give 3.1 mg of INA 9301, which was further subjected to NMR and mass spectrometric analyses.
The MALDI TOF spectrum was recorded on an AXIMA spectrometer (Shimadzu, Japan), while ICR experiments were performed with Fourier Transform acquired on a hybrid Finnigan LTQ FT spectrometer (Thermo Electron, Bremen, Germany) [10] . CID fragmentation was obtained in a linear quadrupole ion trap (number of ions 3·10 4 ). The samples were prepared by the «dry drop» method from aqueous МеОН containing 0.1% TFA. The data were processed by the Xcalibur program (Thermo Electron, Bremen, Germany).
Sample INA 9301 (5 mg) was subjected twice to deuterium exchange in D 2 O, followed by freeze drying. The obtained sample was dissolved in 99.96% D 2 O and then subjected to NMR analysis in a Shigemi tube at 40 o C. TSP (δ H 0.0 ppm), and acetone (δ C 31.45 ppm) were taken as internal standards. A sample for NMR investigation in DMSO-d 6 at 30 o C was obtained without the above described deuterium exchange. Chemical shifts of residual protons (δ H 2.50) and carbons (δ C 39.5) of DMSO-d 6 were used as references. All spectra were recorded on a Bruker DRX-500 spectrometer (Germany). Two-dimensional spectra were obtained using standard Bruker software, and the XWINNMR 3.6 program (Bruker) was used to acquire and process NMR data. Both MLEV17 spin-lock time of 300 ms and a mixing time of 300 ms were used in TOCSY and ROESY experiments, respectively. The HMBC experiment was optimized for coupling constants J H,C of 8 Hz.
